Program

120+ world leading industry experts dedicated to driving forward the potential of 3D tissue models for accurate disease modelling and target discovery will be joining us in Boston this September

Join us to enhance the predictive success of your therapeutic pipeline through insight into the validation techniques utilised by leading experts across the industry.

Have one-to-one in-depth sessions and cross-talk between regulatory, pharma and biotech to discuss future guidelines and clarify the next steps to enhance your pipeline success.

 

Selection of companies who have already joined us:

  • Amgen
  • Biogen
  • Celgene
  • FDA
  • Genentech
  • Pfizer
  • MIT
  • NIH
  • Novo Nordisk

 

Discover how the summit is suited to your research and networking needs by downloading the full event guide!